| Issue |
Section |
Title |
File |
| Vol 2, No 4 (2000) |
Articles |
Profilaktika posleoperatsionnykh venoznykh tromboembolicheskikh oslozhneniy Rossiyskiy konsensus |
|
| Vol 3, No 3 (2001) |
Articles |
Zivoks - novaya vekha v antibiotikoterapii grampolozhitel'nykh infektsiy |
|
| Vol 4, No 1 (2002) |
Articles |
Proekt regional'noy programmy lecheniya pervichno-generalizovannogo (PGRMZh) i metastaticheskogo raka molochnoy zhelezy (MRMZh) |
|
| Vol 4, No 3 (2002) |
Articles |
Rezolyutsiya rabochego soveshchaniya po proektu regional'noy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy |
|
| Vol 5, No 1 (2003) |
Articles |
Proekt Regional'noy programmy lecheniya pervichnykh bol'nykh rakom yaichnikov II'-s-IV stadiy |
|
| Vol 5, No 3 (2003) |
Articles |
Pravitel'stvo Rossiyskoy Federatsii Rasporyazhenie20 marta 2003 g.№357-R |
|
| Vol 5, No 4 (2003) |
Articles |
Proekt Programmy izucheniya neoad\"yuvantnoy terapii nemelkokletochnogo raka legkogo IIIA - IIIB stadiy |
|
| Vol 6, No 3 (2004) |
Articles |
Promezhutochnye rezul'taty i perspektivy realizatsii Vserossiyskoy regional'noy programmy lecheniya mestno-rasprostranennogo i disseminirovannogo raka molochnoy zhelezy |
|
| Vol 6, No 3 (2004) |
Articles |
Informatsiya o nachale provedeniya mezhdunarodnogo issledovaniya metoda lecheniya bol'nykh s follikulyarnoy nekhodzhkinskoy CD20+ V-kletochnoy limfomoy |
|
| Vol 6, No 2 (2004) |
Articles |
Press-konferentsiya «Novye rezul'taty v endokrinnoy terapii raka molochnoy zhelezy» |
|
| Vol 6, No 4 (2004) |
Articles |
Materialy VIII Vserossiyskogo onkologicheskogo kongressa |
|
| Vol 8, No 1 (2006) |
Articles |
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy |
|
| Vol 9, No 2 (2007) |
Articles |
Telekonferentsiya po probleme raka molochnoy zhelezy Moskva, 21 fevralya 2007 g |
|
| Vol 9, No 2 (2007) |
Articles |
Vtoraya konferentsiya patologoanatomov Rossii po voprosam ranney diagnostiki raka molochnoy zhelezy |
|
| Vol 9, No 2 (2007) |
Articles |
Ambulatornoe lechenie khronicheskogo limfoleykoza: doma i steny pomogayut v ramkakh mezhdunarodnogo meditsinskogo simpoziuma «Rekomenduy svobodu!» |
|
| Vol 9, No 2 (2007) |
Articles |
Issledovanie III fazy pokazalo, chto primenenie Neksavara® na 44% uvelichivaet obshchuyu vyzhivaemost' u bol'nykh rakom pecheni 4 iyunya 2007 g., Berlin |
|
| Vol 9, No 3 (2007) |
Articles |
Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy |
|
| Vol 9, No 3 (2007) |
Articles |
Regional'naya programma lecheniya raka yaichnika IIB–IV stadii |
|
| Vol 10, No 1 (2008) |
Articles |
8 let nadezhdy: novye dannye issledovaniya ATAS |
|
| Vol 9, No 4 (2007) |
Articles |
Zlokachestvennye opukholi golovnogo mozga: sovremennye standarty i perspektivy |
|
| Vol 10, No 1 (2008) |
Articles |
Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii |
|
| Vol 9, No 4 (2007) |
Articles |
Zaregistrirovany rasshireniya pokazaniy k ispol'zovaniyu Avastina i Kselody u patsientok s metastaticheskim kolorektal'nym rakom v Evrope |
|
| Vol 10, No 1 (2008) |
Articles |
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes) |
|
| Vol 10, No 2 (2008) |
Articles |
ASCO Innovatsionnye metody bor'by s onkologicheskimi zabolevaniyam |
|
| Vol 10, No 2 (2008) |
Articles |
Reshenie ekspertnogo soveshchaniya«Novye vozmozhnosti profilaktiki i lecheniya invazivnykh gribkovykh infektsiy» |
|
| Vol 10, No 3 (2008) |
Articles |
Press-reliz Novaya era v lechenii raka pochki |
|
| Vol 10, No 3 (2008) |
Articles |
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii |
|
| Vol 10, No 3 (2008) |
Articles |
Press-reliz Novye vozmozhnosti v lechenii raka pecheni |
|
| Vol 10, No 4 (2008) |
Articles |
Itogovyy press-reliz |
|
| Vol 10, No 4 (2008) |
Articles |
Novyy shag k prodleniyu zhizni bol'nykh metastaticheskim rakom pecheni |
|
| Vol 11, No 1 (2009) |
Articles |
Press-reliz Targetnaya terapiya nemelkokletochnogo raka legkogo: nastoyashchee i budushchee |
|
| Vol 11, No 1 (2009) |
Articles |
Media-reliz Vedushchiy mezhdunarodnyy meditsinskiy zhurnal «The Lancet» svidetel'stvuet:Preparat Glivek® znachitel'no snizhaet risk razvitiya retsidivau patsientov s gastrointestinal'nymi stromal'nymi opukholyami |
|
| Vol 11, No 1 (2009) |
Articles |
Press-reliz Telemost prines radostnuyu vest' |
|
| Vol 11, No 2 (2009) |
Articles |
Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL) |
|
| Vol 11, No 3 (2009) |
Articles |
Press-reliz Na IV Kongresse Rossiyskogo obshchestva onkourologov v Moskve obsudili targetnuyu terapiyu raka pochki i preimushchestva preparata Neksavar |
|
| Vol 11, No 3 (2009) |
Articles |
Press-reliz Evropeyskaya komissiya utverdila rasshirenie pokazaniy k primeneniyu Avastina, odobriv ego kombinatsiyus dotsetakselom v kachestve terapii 1-y linii dlya lecheniya rasprostranennogo (metastaticheskogo) raka molochnoy zhelezy |
|
| Vol 11, No 3 (2009) |
Articles |
Press-reliz Novoe protivoopukholevoe soedinenie regorafenib (BAY 73-4506) kompanii «Bayer» obespechilo stabilizatsiyu ili regressiyu u 81% bol'nykh rakom pochki |
|
| Vol 11, No 3 (2009) |
Articles |
Press-reliz Vektibiks v kombinatsii s khimioterapiey v kachestve pervoy i vtoroy liniy terapii znachitel'no udlinyaet period bez progressirovaniya u bol'nykh metastaticheskim rakom tolstoy i pryamoy kishki. |
|
| Vol 11, No 4 (2009) |
Articles |
Glivek v ad\"yuvantnoy terapii gastro-intestinal'nykh stromal'nykh opukholey. Novoe pokazanie – novye vozmozhnosti |
|
| Vol 11, No 4 (2009) |
Articles |
Press-reliz Glioblastoma: novye gorizonty lekarstvennoy terapii |
|
| Vol 11, No 4 (2009) |
Articles |
Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni |
|
| Vol 11, No 4 (2009) |
Articles |
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin |
|
| Vol 12, No 1 (2010) |
Articles |
Nauchno-prakticheskaya konferentsiya«Profilaktika i lechenie trombozovven i tromboemboliy u bol'nykhs onkologicheskimi zabolevaniyami» |
|
| Vol 12, No 2 (2010) |
Articles |
Kommyunike dlya SMI |
|
| Vol 12, No 3 (2010) |
Articles |
Na territorii Rossiyskoy FederatsiiGertseptin zaregistrirovan v kachestve terapiirasprostranennoy adenokartsinomy zheludkaili pishchevodno-zheludochnogo perekhodas opukholevoy giperekspressiey HER2 |
|
| Vol 12, No 4 (2010) |
Articles |
25 noyabrya 2010 g. «AstraZeneka Rossiya» ob\"yavilapromezhutochnye rezul'taty issledovaniya EPICLIN |
|
| Vol 12, No 4 (2010) |
Articles |
V Rossii startoval innovatsionnyy proekt «GistoLogika»Moskva, dekabr' 2010 g. |
|
| Vol 12, No 4 (2010) |
Articles |
Analiz bazovykh issledovaniy III fazy podtverzhdaetpreimushchestvo denosumaba pered standartnoy terapieyu bol'nykh s metastaticheskim porazheniem kostey |
|
| Vol 13, No 2 (2011) |
Articles |
Kompaniya «Eli Lilli» ob\"yavila promezhutochnyerezul'taty issledovaniya PARAMOUNT |
|
| Vol 13, No 2 (2011) |
Articles |
Novye vozmozhnosti targetnoy terapiirasprostranennogo raka pochki |
|
| Vol 13, No 2 (2011) |
Articles |
Novye strategii terapii zlokachestvennykhlimfoproliferativnykh zabolevaniyobsuzhdalis' v Sankt-Peterburgena forume onkogematologov |
|
| Vol 15, No 3 (2013) |
Articles |
Press-reliz Preparat Avastin® odobren v Rossii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom v 1 i 2-y liniyakh terapii nepreryvno |
|
| Vol 15, No 4 (2013) |
Articles |
X russian conference with international participation «Malignant lymphomas», 24–25 October, 2013, Moscow |
|
| Vol 15, No 4 (2013) |
Articles |
RIBOMUSTINE (BENDAMUSTINE) IS APPROVED FOR THE TREATMENT IN MULTIPLE MYELOMA PATIENTS IN RUSSIA FEDERATION |
|
| Vol 15, No 4 (2013) |
Articles |
Brest cancer: international online cooperation on sharing experience |
|
| Vol 16, No 1 (2014) |
Articles |
Press-release. The resolution of oncologists of the North-West Federal District: screening for female reproductive system cancers is required |
|
| Vol 15, No 4 (2013) |
Articles |
Rossiyskaya regional'naya programma: ad\"yuvantnaya khimioterapiya rannego raka molochnoy zhelezy rezhimami na osnove Taksotera (Re-Tac) |
|
| Vol 16, No 2 (2014) |
Articles |
Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI |
|
| Vol 16, No 2 (2014) |
Articles |
Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards |
|
| Vol 16, No 3 (2014) |
Articles |
Press Release. New data show Giotrif® (afatinib) provided more than one year additional survival for patients with lung cancer associated with the most common type of EGFR mutation (del19) compared to chemotherapy |
|
| Vol 16, No 4 (2014) |
Articles |
Press release |
|
| Vol 16, No 4 (2014) |
Articles |
Press releaseThe resolution of the expert council for targeted therapy of radioactive iodine-refractory differentiated thyroid cancer |
|
| Vol 17, No 1 (2015) |
Articles |
Press-reliz «Novoe sozvezdie preparatov dlya lecheniya HER2-polozhitel'nogo raka molochnoy zhelezy»: satellitnyy simpozium kompanii «Rosh» v ramkakh bol'shoy konferentsii RUSSCO «Rak molochnoy zhelezy» |
|
| Vol 17, No 2 (2015) |
Articles |
Zaltrap® (aflibertsept) stanet dostupnym v Rossiyskoy Federatsii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom |
|
| Vol 17, No 2 (2015) |
Articles |
Preparat Gaziva® stanet dostupen dlya terapii patsientov s khronicheskim limfotsitarnym leykozom |
|
| Vol 17, No 3 (2015) |
Articles |
Pamyati Gianni Bonadonna |
|
| Vol 17, No 3 (2015) |
Articles |
Press-release Combination treatment with Vargatef® and docetaxel contributes to statistically significant tumor reduction in patients with progressive adenocarcinoma of the lung in comparison with docetaxel in monotherapy |
|
| Vol 17, No 4 (2015) |
Articles |
FDA approves Opdivo to treat advanced form of kidney cancer |
|
| Vol 17, No 4 (2015) |
Articles |
FDA approves ixazomib in combination with lenalidomide and dexamethasone for multiple myeloma |
|
| Vol 17, No 4 (2015) |
Articles |
Review of the Event: The role of local biosimilar drugs and original biological drugs in modern cancer treatment |
|
| Vol 17, No 3 (2015) |
Articles |
Atsellbiya® - opyt primeneniya pervogo bioanaloga rituksimaba v rutinnoy praktike klinitsista |
|
| Vol 17, No 5 (2015) |
Articles |
Press release | October 21, 2015XII Annual Russian Conference with International Participation "Malignant Lymphomas" Symposium "New perspectives in the treatment of chronic lymphocytic leukemia" |
|
| Vol 13, No 1 (2011) |
Articles |
Press-relizEkspertnyy sovet Rossiyskogo obshchestva onkogematologovDiagnostika i lechenie bol'nykh khronicheskim limfoleykozom vysokogo riska |
|
| Vol 13, No 1 (2011) |
Articles |
Spraysel odobren v Rossii dlya vzroslykh patsientovs vpervye vyyavlennym khronicheskim mieloidnym leykozom (KhML) |
|
| Vol 13, No 1 (2011) |
Articles |
Dannye dolgosrochnogo nablyudeniya podtverzhdayut, chto razrabotannyy kompaniey Novartispreparat TasignaR prevoskhodit preparat GlivekR po snizheniyu riska progressirovaniyazabolevaniya u patsientov s vpervye diagnostirovannym khronicheskim mieloleykozom |
|
| Vol 13, No 1 (2011) |
Articles |
Na IV forume Dvizhenie protiv raka predlozheno sozdat' programmu Natsional'noy strategiisnizheniya smertnosti ot onkologicheskikh zabolevaniy |
|
| Vol 13, No 3 (2011) |
Articles |
Mul'tidistsiplinarnyy podkhodk diagnostike i lecheniyu raka molochnoyzhelezy - vpervye na Forume ekspertov |
|
| Vol 13, No 3 (2011) |
Articles |
Puti resheniya aktual'nykh problemneyroonkologii |
|
| Vol 13, No 3 (2011) |
Articles |
Tasigna odobrena v Rossiidlya lecheniya vzroslykh patsientovs vpervye vyyavlennym khronicheskimmieloidnym leykozom (KhML) |
|
| Vol 13, No 3 (2011) |
Articles |
Rak molochnoy zhelezy.Kak reshit' problemu finansirovaniya lecheniyasoglasno mezhdunarodnym standartam |
|
| Vol 13, No 3 (2011) |
Articles |
Minzdravsotsrazvitiya RF: predlozhenieobshchestva po spisku ZhNVLP poluchilo odobrenie |
|
| Vol 13, No 4 (2011) |
Articles |
Predstaviteli Rossiyskogo onkologicheskogosoobshchestva i Komiteta Soveta Federatsiipo sotsial'noy politike i zdravookhraneniyudogovorilis' sovmestno borot'sya s rakommolochnoy zhelezy v Rossii |
|
| Vol 13, No 4 (2011) |
Articles |
17 noyabrya 2011 g. v ramkakh X Natsional'nogoonkologicheskogo kongressa sostoyalsyasimpozium «Biosimilyary: novye gorizontyrazvitiya zdravookhraneniya» |
|
| Vol 13, No 4 (2011) |
Articles |
«Rosh» i «Farmstandart»:god strategicheskogo partnerstva |
|
| Vol 13, No 4 (2011) |
Articles |
Novye rekomendatsii EORTC po primeneniyugranulotsitarno-koloniestimuliruyushchegofaktora (G-KSF) dlya snizheniya riskarazvitiya febril'noy neytropenii (FN)u vzroslykh patsientov s limfomamii solidnymi opukholyami.Algoritm opredeleniya riska razvitiya FNi primenenie G-KSF |
|
| Vol 14, No 1 (2012) |
Articles |
V pamyat' o M.M.Kaverznevoy |
|
| Vol 14, No 1 (2012) |
Articles |
K 80-letiyu so dnya rozhdeniya akademika RAMNL'va Abramovicha Durnova (1931-2005) |
|
| Vol 14, No 1 (2012) |
Articles |
Podvedeny itogi I Vserossiyskoy premiiv oblasti onkologii «IN VITA VERITAS» |
|
| Vol 14, No 2 (2012) |
Articles |
V Moskve sostoyalos' obsuzhdenie proekta Rossiyskikh klinicheskikh rekomendatsiy po diagnostike i lecheniyu zlokachestvennykh limfoproliferativnykh zabolevaniy, osnovannykh na printsipakh dokazatel'noy meditsiny i mnenii ekspertov |
|
| Vol 14, No 2 (2012) |
Articles |
Issledovanie III fazy: znachitel'noe uvelichenie prodolzhitel'nosti zhizni u patsientov s naibolee rasprostranennym tipom nemelkokletochnogo raka legkogo, poluchavshikh prodolzhennuyu podderzhivayushchuyu terapiyu na osnove preparata Alimta |
|
| Vol 14, No 2 (2012) |
Articles |
Dzhevtana® (kabazitaksel) - novyy preparat dlya lecheniya metastaticheskogo gormonorezistentnogo raka predstatel'noy zhelezy zaregistrirovan v Rossii |
|
| Vol 14, No 2 (2012) |
Articles |
Novye vozmozhnosti targetnoy terapii v onkodermatologii |
|
| Vol 14, No 3 (2012) |
Articles |
22 sentyabrya 2012 g. sostoyalsya press-brifing, posvyashchennyy roli targetnoy terapii v preodolenii lekarstvennoy rezistentnosti pri lechenii metastaticheskogo raka molochnoy zhelezy (mRMZh) i, v chastnosti, predstavleniyu obshchestvennosti novykh zaregistrirovannykh pokazaniy dlya primeneniya preparata Afinitor pri mRMZh |
|
| Vol 14, No 3 (2012) |
Articles |
Internet-konferentsiya «Follikulyarnye limfomy» |
|
| Vol 14, No 4 (2012) |
Articles |
Moskva, 5 noyabrya. VII Forum ekspertov po diagnostike i lecheniyu raka molochnoy zhelezy (Rim, 2-5 noyabrya 2012 g.) |
|
| Vol 14, No 4 (2012) |
Articles |
Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg |
|
| Vol 14, No 4 (2012) |
Articles |
V Rossii zaregistrirovan Ksalkori®(krizotinib) kak pervyy i edinstvennyypreparat dlya lecheniya ALK-pozitivnogonemelkokletochnogo raka legkogo |
|
| Vol 14, No 4 (2012) |
Articles |
Obrazovatel'nye meropriyatiyav oblasti abdominal'noy onkologii |
|
| Vol 14, No 4 (2012) |
Articles |
Opyt provedeniya nablyudatel'nykhprogramm v abdominal'noy onkologii |
|
| Vol 21, No 3 (2019) |
Articles |
The issues of treatment of primary refractory and relapse patients with diffuse large B-cell lymphoma in the Russian Federation. What awaits us in the future? |
(Rus)
|
